Skip to main content

Advertisement

SpringerLink
Log in

Aloin protects against arsenic trioxide–induced myocardial membrane damage and release of inflammatory cytokines

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Aloin exerts concentration-dependent pro-oxidant and antioxidant effects when tested in vitro. Such duality of effects has not been investigated through in vivo studies on aloin. We evaluated the effects of aloin at doses ranging between 1 and 125 mg/kg against the arsenic trioxide (As2O3)–induced cardiotoxicity in mice. As2O3 (5 mg/kg/day) was intraperitoneally administrated for 10 days. Aloin was administered through oral gavage at 1, 5, 25, and 125 mg/kg/day. As2O3 induced rise in ST height and QT interval in ECG, increased oxidative stress, and depleted the antioxidative defense. As2O3 increased inflammatory cytokine concentrations in the heart. Aloin dose dependently inhibited the As2O3-induced cardiotoxicity. There was no evidence of increased oxidative stress in the low-dose aloin-treated mice receiving As2O3. Our results indicate that aloin possesses cardioprotective potentials and its pro-oxidant effect is not evident in vivo at tested doses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Ahangarpour A, Zeidooni L, Rezaei M, Alboghobeish S, Samimi A, Oroojan AA (2017) Protective effect of metformin on toxicity of butyric acid and arsenic in isolated liver mitochondria and Langerhans islets in male mice: an in vitro study. Iran J Basic Med Sci 20:1297

    PubMed  PubMed Central  Google Scholar 

  • Alamolhodaei NS, Shirani K, Karimi G (2015) Arsenic cardiotoxicity: an overview. Environ Toxicol Pharmacol 40:1005–1014

    Article  CAS  Google Scholar 

  • Bhattacharjee S, Pal S (2014) Antilipidemic and cardioprotective effects of vitamin B 12 and folic acid against arsenic toxicity. Int J Pharm Chem Biol Sci 4

  • Cui Y, Ye Q, Wang H, Li Y, Xia X, Yao W, Qian H (2014) Aloin protects against chronic alcoholic liver injury via attenuating lipid accumulation, oxidative stress and inflammation in mice. Arch Pharm Res 37:1624–1633

    Article  CAS  Google Scholar 

  • Dhawan D, Balasubramanian S, Amonkar AJ, Singh N (1999) Chemopreventive effect of 4′-demethyl epipodophyllotoxin on DMBA/TPA-induced mouse skin carcinogenesis. Carcinogenesis 20:997–1003

    Article  CAS  Google Scholar 

  • Floyd RA (1999) Methods in molecular biology. In: Armstrong D (ed) Free radical and antioxidant protocols, vol 108. Humana Press, Totowa 455 pp

    Google Scholar 

  • Groom Q, Reynolds T (1987) Barbaloin in Aloe species. Planta Med 53:345–348

    Article  CAS  Google Scholar 

  • Hamiza O, Rehman M, Khan R, Tahir M, Khan A, Lateef A, Sultana S (2014) Chemopreventive effects of aloin against 1, 2-dimethylhydrazine-induced preneoplastic lesions in the colon of Wistar rats. Hum Exp Toxicol 33:148–163

    Article  CAS  Google Scholar 

  • Hemmati A, Olapour S, Varzi HN, Khodayar M, Dianat M, Mohammadian B, Yaghooti H (2018) Ellagic acid protects against arsenic trioxide–induced cardiotoxicity in rat. Hum Exp Toxicol 37:412–419

    Article  CAS  Google Scholar 

  • Jamieson N, Sirdaarta J, Cock I (2014) The anti-proliferative properties of Australian plants with high antioxidant capacities against cancer cell lines. Pharmacogn Commun:4

  • Kemp GJ (2004) Mitochondrial dysfunction in chronic ischemia and peripheral vascular disease. Mitochondrion 4:629–640

    Article  CAS  Google Scholar 

  • Kono Y, Fridovich I (1982) Superoxide radical inhibits catalase. J Biol Chem 257:5751–5754

    CAS  PubMed  Google Scholar 

  • Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta (BBA) Gen Subj 582:67–78

    Article  CAS  Google Scholar 

  • Ohkawa H, Ohishi N, Yagi K (1978) Reaction of linoleic acid hydroperoxide with thiobarbituric acid. J Lipid Res 19:1053–1057

    CAS  PubMed  Google Scholar 

  • Pulido MD, Parrish AR (2003) Metal-induced apoptosis: mechanisms. Mutat Res Fundam Mol Mech Mutagen 533:227–241

    Article  CAS  Google Scholar 

  • Radha MH, Laxmipriya NP (2015) Evaluation of biological properties and clinical effectiveness of Aloe vera: a systematic review. J Tradit Complement Med 5:21–26

    Article  Google Scholar 

  • Sonawane VK et al (2018) A chemosensitizer drug: disulfiram prevents doxorubicin-induced cardiac dysfunction and oxidative stress in rats. Cardiovasc Toxicol 18:459–470

    Article  CAS  Google Scholar 

  • Tian B, Hua Y (2005) Concentration-dependence of prooxidant and antioxidant effects of aloin and aloe-emodin on DNA. Food Chem 91:413–418

    Article  CAS  Google Scholar 

  • Varghese MV, Abhilash M, Alex M, Paul MS, Prathapan A, Raghu K, Nair RH (2017) Attenuation of arsenic trioxide induced cardiotoxicity through flaxseed oil in experimental rats. Redox Rep 22:346–352

    Article  CAS  Google Scholar 

  • Wamer WG, Vath P, Falvey DE (2003) In vitro studies on the photobiological properties of aloe emodin and aloin A. Free Radic Biol Med 34:233–242

    Article  CAS  Google Scholar 

  • Wang M et al (2013) Salvianolic acid B prevents arsenic trioxide-induced cardiotoxicity in vivo and enhances its anticancer activity in vitro. Evid Based Complement Alternat Med:2013

  • Zhang W, Guo C, Gao R, Ge M, Zhu Y, Zhang Z (2013) The protective role of resveratrol against arsenic trioxide-induced cardiotoxicity. Evid Based Complement Alternat Med:2013

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule, Maharashtra, 425405, India

    Lalit A. Birari, Umesh B. Mahajan, Kalpesh R. Patil, Neha A. Bagul, Sameer N. Goyal & Chandragouda R. Patil

  2. Department of Pharmaceutical Chemistry, H. R. Patel Institute of Pharmaceutical Education and Research, Shirpur, Dist. Dhule, Maharashtra, 425405, India

    Dipak D. Patil

  3. Department of Pharmacology, School of Pharmacy & Technology Management, SVKM’s NMIMS, Shirpur, Dist. Dhule, Maharashtra, 425405, India

    Sateesh Belemkar

  4. Shri Vile Parle Kelavani Mandal’s Institute of Pharmacy, Dhule, Maharashtra, 424 001, India

    Sameer N. Goyal

  5. Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box 17666, Al Ain, Abu Dhabi, United Arab Emirates

    Shreesh Ojha

Authors
  1. Lalit A. Birari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Umesh B. Mahajan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kalpesh R. Patil
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dipak D. Patil
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Neha A. Bagul
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sateesh Belemkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sameer N. Goyal
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shreesh Ojha
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Chandragouda R. Patil
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

L. A. B., N. A. B., U. B. M. and C. R. P. carried out the literature search and conducted the animal studies, analyzed the results, and wrote the first draft of the manuscript. S. N. G. and S. O. helped in designing the study. D. D. P. carried out the analytical studies. S. B. and K. R. P. contributed to the design of the study and overall supervision. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Chandragouda R. Patil.

Ethics declarations

The study animals were maintained according to the guidelines of the Committee for the Purpose of Control and Supervision of the Experiments on Animals (CPCSEA) established under the Prevention of the Cruelty to Animals Act, 1960, Ministry of Environment and Forests, Government of India. The institutional animal ethics committee reviewed and sanctioned the experimental protocol (protocol approval no. IAEC/CPCSEA/RCPIPER/2018/19-03). The tests performed in this study complied with the protocols of the International Association for the Study of Pain.

Conflict of interest

The authors declare that there is no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Birari, L.A., Mahajan, U.B., Patil, K.R. et al. Aloin protects against arsenic trioxide–induced myocardial membrane damage and release of inflammatory cytokines. Naunyn-Schmiedeberg's Arch Pharmacol 393, 1365–1372 (2020). https://doi.org/10.1007/s00210-020-01833-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-020-01833-1

Keywords

Search

Navigation